- Home
- IDE vs PALI Comparison
IDE vs PALI Comparison
Compare IDE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IDE | PALI |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.7M | 240.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | IDE | PALI |
|---|---|---|
| Price | $13.53 | $2.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $11.29 |
| AVG Volume (30 Days) | 53.9K | ★ 5.1M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 8.83% | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $10.40 | $0.55 |
| 52 Week High | $14.30 | $2.86 |
Technical Indicators
Market Signals| Indicator | IDE | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 48.97 |
| Support Level | $13.23 | $1.57 |
| Resistance Level | $13.52 | $2.09 |
| Average True Range (ATR) | 0.29 | 0.22 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 74.49 | 26.29 |
Price Performance
Historical ComparisonAbout IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.